ILYX-002

N/A

Report date: 2025/04/03 10:15:34
NME

Base Information

Drug NameILYX-002
Drug Alias NameILYX-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTh1 cells modulatorsTh17 cells modulators
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIolyx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIolyx Australia Pty LtdIolyx Therapeutics IncThéa Open Innovation +[4] 
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A